Adjuvant Embolization With N-Butyl Cyanoacrylate in the Treatment of Cerebral Arteriovenous Malformations Outcomes, Complications, and Predictors of Neurologic Deficits

被引:77
作者
Starke, Robert M.
Komotar, Ricardo J.
Otten, Marc L.
Hahn, David K. [2 ]
Fischer, Laura E.
Hwang, Brian Y.
Garrett, Matthew C.
Sciacca, Robert R.
Sisti, Michael B.
Solomon, Robert A.
Lavine, Sean D. [3 ]
Connolly, E. Sander
Meyers, Philip M. [1 ,3 ]
机构
[1] Columbia Univ, Dept Neurosurg, Neurol Inst, New York, NY 10032 USA
[2] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA
[3] Columbia Univ, Dept Intervent Neuroradiol, New York, NY 10032 USA
关键词
arteriovenous malformation; complication; embolization; outcome; surgery; PREOPERATIVE EMBOLIZATION; ENDOVASCULAR TREATMENT; GRADING SYSTEM; STEREOTAXIC RADIOSURGERY; SURGICAL-MANAGEMENT; BASAL GANGLIA; BRAIN; EXPERIENCE; DETERMINANTS; SURGERY;
D O I
10.1161/STROKEAHA.108.539775
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The purpose of this study was to assess the frequency, severity, and predictors of neurological deficits after adjuvant embolization for cerebral arteriovenous malformations. Methods-From 1997 to 2006, 202 of 275 patients with arteriovenous malformation received embolization before microsurgery (n = 176) or radiosurgery (n = 26). Patients were examined before and after endovascular embolization and at clinical follow-up (mean, 43.4 +/- 34.6 months). Outcome was classified according to the modified Rankin Scale. New neurological deficits after embolization were defined as minimal (no change in overall modified Rankin Scale), moderate (modified Rankin Scale <= 2), or significant (modified Rankin Scale > 2). Results-Two hundred two patients were treated in 377 embolization procedures. There were a total of 29 new clinical deficits after embolization (8% of procedures; 14% of patients), of which 19 were moderate or significant. Postembolization deficits resolved in a significant number of patients over time (P < 0.0001). Five patients had persistent neurological deficits due to embolization (1.3% of procedures; 2.5% of patients). In multivariate analysis, the following variables significantly predicted new neurological deficit after embolization: complex arteriovenous malformation with treatment plan specifying more than one embolization procedure (OR, 2.7; 95% CI, 1.4 to 8.6), diameter < 3 cm (OR, 3.2; 95% CI, 1.2 to 9.1), diameter > 6 cm (OR, 6.2; 95% CI, 1.0 to 57.0), deep venous drainage (OR, 2.7; 95% CI, 1.1 to 6.9), or eloquent location (OR, 2.4; 95% CI, 1.0 to 5.7). These variables were weighted and used to compute an arteriovenous malformation Embolization Prognostic Risk Score for each patient. A score of 0 predicted no new deficits, a score of 1 predicted a new deficit rate of 6%, a score of 2 predicted a new deficit rate of 15%, a score of 3 predicted a new deficit rate of 21%, and a score of 4 predicted a new deficit rate of 50% (P < 0.0001). Conclusions-Small and large size, eloquent location, deep venous drainage, and complex vascular anatomy requiring multiple embolization procedures are risk factors for the development of immediate postembolization neurological deficits. Nevertheless, a significant number of patients with treatment-related neurological deficits improve over time. The low incidence of permanent neurological deficits underscores the usefulness of this technique in carefully selected patients. (Stroke. 2009; 40: 2783-2790.)
引用
收藏
页码:2783 / 2790
页数:8
相关论文
共 68 条
[1]  
Altman DG., 1996, PRACTICAL STAT MED R, V7th
[2]   Embolization before radiosurgery reduces the obliteration rate of artericivenous malformations [J].
Andrade-Souza, Yuri M. ;
Ramani, Meera ;
Scora, Daryl ;
Tsao, May N. ;
terBrugge, Karel ;
Schwartz, Michael L. .
NEUROSURGERY, 2007, 60 (03) :443-451
[3]   INTRACRANIAL ARTERIOVENOUS MALFORMATION - RELATIONSHIP BETWEEN CLINICAL FACTORS AND SURGICAL COMPLICATIONS [J].
BATJER, HH ;
DEVOUS, MD ;
SEIBERT, GB ;
PURDY, PD ;
BONTE, FJ .
NEUROSURGERY, 1989, 24 (01) :75-79
[4]   EMBOLIZATION OF CEREBRAL ARTERIOVENOUS-MALFORMATIONS WITH BUCRYLATE - EXPERIENCE IN 46 CASES [J].
DEBRUN, G ;
VINUELA, F ;
FOX, A ;
DRAKE, CG .
JOURNAL OF NEUROSURGERY, 1982, 56 (05) :615-627
[5]   Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate [J].
Debrun, GM ;
Aletich, V ;
Ausman, JI ;
Charbel, F ;
Dujovny, M .
NEUROSURGERY, 1997, 40 (01) :112-120
[6]  
DEMERITT JS, 1995, AM J NEURORADIOL, V16, P1801
[7]   Complications after multidisciplinary treatment of cerebral arteriovenous malformations [J].
Deruty, R ;
PelissouGuyotat, I ;
Amat, D ;
Mottolese, C ;
Bascoulergue, Y ;
Turjman, F ;
Gerard, JP .
ACTA NEUROCHIRURGICA, 1996, 138 (02) :119-131
[8]   THE COMBINED MANAGEMENT OF CEREBRAL ARTERIOVENOUS-MALFORMATIONS - EXPERIENCE WITH 100 CASES AND REVIEW OF THE LITERATURE [J].
DERUTY, R ;
PELISSOUGUYOTAT, I ;
MOTTOLESE, C ;
BASCOULERGUE, Y ;
AMAT, D .
ACTA NEUROCHIRURGICA, 1993, 123 (3-4) :101-112
[9]  
Duong DH, 1999, NEW ENGL J MED, V340, P1812
[10]   Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations [J].
Duong, DH ;
Young, WL ;
Vang, MC ;
Sciacca, RR ;
Mast, H ;
Koennecke, HC ;
Hartmann, A ;
Joshi, S ;
Mohr, JP ;
Pile-Spellman, J .
STROKE, 1998, 29 (06) :1167-1176